Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Immune-globulin

Various toxicities

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jones D, et al. MANAGING PRIMARY IMMUNODEFICIENCY IMMUNOGLOBULIN REPLACEMENT THERAPY-RELATED ADVERSE EVENTS: PROPHYLAXIS WITH RECOMBINANT HUMAN C1 ESTERASE INHIBITOR. Annals of Allergy, Asthma and Immunology 131 (Suppl.): S148, No. 5, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/j.anai.2023.08.450 [abstract] Jones D, et al. MANAGING PRIMARY IMMUNODEFICIENCY IMMUNOGLOBULIN REPLACEMENT THERAPY-RELATED ADVERSE EVENTS: PROPHYLAXIS WITH RECOMBINANT HUMAN C1 ESTERASE INHIBITOR. Annals of Allergy, Asthma and Immunology 131 (Suppl.): S148, No. 5, Nov 2023. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​anai.​2023.​08.​450 [abstract]
Metadaten
Titel
Immune-globulin
Various toxicities
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55210-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Pembrolizumab

Case report

Sotalol

Case report

Multiple drugs